SuperworthDamora Therapeutics market cap DMRA
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $1.3B
- Highest close in our data
- $1.9B
- Jul 2026
Damora Therapeutics is worth $1.3B at the close on Oct 23, 2026, at $21.09 a share.
That is up 11560% over the last year and up 1462% over five years.
Its highest close in our data was $1.9B in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.3B | $27.2M | $1.9B | +2773% |
| 2025 | $45.3M | $3.1M | $45.3M | +568% |
| 2024 | $6.8M | $6.2M | $23.6M | −65% |
| 2023 | $19.5M | $14.5M | $77.5M | −34% |
| 2022 | $29.4M | $29.4M | $74.1M | −62% |
| 2021 | $76.5M | $60.6M | $328.4M | −76% |
| 2020 | $316M | $316M | $355.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Damora Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DMRADamora Therapeutics | $1.3B |
| OMEROmeros | $1.2B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| ANIPANI Pharmaceuticals | $1.7B |
| ABUSArbutus Biopharma | $831M |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Damora Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.